152 related articles for article (PubMed ID: 21319508)
1. Percutaneous nephrostomy in the management of advanced and terminal-stage gynecologic malignancies: outcome and complications.
Plesinac-Karapandzic V; Masulovic D; Markovic B; Djuric-Stefanovic A; Plesinac S; Vucicevic D; Milovanovic Z; Milosevic Z
Eur J Gynaecol Oncol; 2010; 31(6):645-50. PubMed ID: 21319508
[TBL] [Abstract][Full Text] [Related]
2. Mortality and complications associated with percutaneous nephrostomy in patients with ureteral obstruction related to advanced cervical cancer.
Cardona AF; Garzón JR; Burgos E; Abenoza LM; Cortés JA; Ramos PL
J Palliat Care; 2006; 22(4):315. PubMed ID: 17263063
[No Abstract] [Full Text] [Related]
3. Percutaneous nephrostomy in gynecologic oncology patients.
Soper JT; Blaszczyk TM; Oke E; Clarke-Pearson D; Creasman WT
Am J Obstet Gynecol; 1988 May; 158(5):1126-31. PubMed ID: 2453117
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-guided percutaneous nephrostomy in the treatment of advanced gynecologic malignancy.
Pedersen H; Juul N
Acta Obstet Gynecol Scand; 1988; 67(3):199-201. PubMed ID: 3176936
[TBL] [Abstract][Full Text] [Related]
5. Role of percutaneous nephrostomy (PCN) in malignant ureteral obstruction.
Jalbani MH; Deenari RA; Dholia KR; Oad AK; Arbani IA
J Pak Med Assoc; 2010 Apr; 60(4):280-3. PubMed ID: 20419970
[TBL] [Abstract][Full Text] [Related]
6. Win or lose? Percutaneous nephrostomy for a terminal-stage cervical-cancer patient featuring obstructive uropathy.
Chang HL; Lim HW; Su FH; Tsai ST; Wang YW
J Palliat Care; 2006; 22(1):57-60. PubMed ID: 16689418
[No Abstract] [Full Text] [Related]
7. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies.
Song Y; Fei X; Song Y
Int J Gynecol Cancer; 2012 May; 22(4):697-702. PubMed ID: 22315095
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous nephrostomy for ureteric obstruction due to advanced pelvic malignancy: have we got the balance right?
Misra S; Coker C; Richenberg J
Int Urol Nephrol; 2013 Jun; 45(3):627-32. PubMed ID: 23666587
[TBL] [Abstract][Full Text] [Related]
9. Ureteric stents vs percutaneous nephrostomy for initial urinary drainage in children with obstructive anuria and acute renal failure due to ureteric calculi: a prospective, randomised study.
ElSheemy MS; Shouman AM; Shoukry AI; ElShenoufy A; Aboulela W; Daw K; Hussein AA; Morsi HA; Badawy H
BJU Int; 2015 Mar; 115(3):473-9. PubMed ID: 24698195
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
[TBL] [Abstract][Full Text] [Related]
11. The role of percutaneous nephrostomy in malignant ureteric obstruction.
Wilson JR; Urwin GH; Stower MJ
Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
[TBL] [Abstract][Full Text] [Related]
12. Factors Affecting Survival Outcome After Percutaneous Nephrostomy as Palliative Urinary Diversion in Obstructive Uropathy due to Advance Cervical Cancer Patients.
Noegroho BS; Kurniawan AP; Wijayanti Z; Mustafa A
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1211-1216. PubMed ID: 33906314
[TBL] [Abstract][Full Text] [Related]
13. [Percutaneous nephrostomy at the Second Kaunas Clinical Hospital].
Matjosaitis A; Rinkūnas G; Bosas P
Medicina (Kaunas); 2002; 38 Suppl 1():76-8. PubMed ID: 12556641
[TBL] [Abstract][Full Text] [Related]
14. Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with terminal cervical cancer.
Emmert C; Rassler J; Köhler U
Arch Gynecol Obstet; 1997; 259(3):147-51. PubMed ID: 9187468
[TBL] [Abstract][Full Text] [Related]
15. The management of malignant ureteral obstruction treated with ureteral stents.
Ganatra AM; Loughlin KR
J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
[TBL] [Abstract][Full Text] [Related]
16. Nephrostomy insertion for patients with bilateral ureteric obstruction caused by prostate cancer.
Nariculam J; Murphy DG; Jenner C; Sellars N; Gwyther S; Gordon SG; Swinn MJ
Br J Radiol; 2009 Jul; 82(979):571-6. PubMed ID: 19153185
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up results and complications in cancer patients with persistent nephrostomy due to malignant ureteral obstruction.
Alma E; Ercil H; Vuruskan E; Altunkol A; Unal U; Gurlen G; Goren V; Gurbuz ZG
Support Care Cancer; 2020 Nov; 28(11):5581-5588. PubMed ID: 32757161
[TBL] [Abstract][Full Text] [Related]
19. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
[TBL] [Abstract][Full Text] [Related]
20. Racial disparities in the use of palliative therapy for ureteral obstruction among elderly patients with advanced prostate cancer.
Spencer BA; Insel BJ; Hershman DL; Benson MC; Neugut AI
Support Care Cancer; 2013 May; 21(5):1303-11. PubMed ID: 23292697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
